Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
844.8 DKK | +1.34% | +3.25% | +9.43% |
Jun. 06 | Transcript : Coloplast A/S - Analyst/Investor Day | |
May. 15 | COLOPLAST : Multiple silver linings in spite of a soft Q2 24 |
Sales 2024 * | 27.02B 3.89B | Sales 2025 * | 29.35B 4.22B | Capitalization | 187B 26.95B |
---|---|---|---|---|---|
Net income 2024 * | 5.24B 753M | Net income 2025 * | 6.1B 878M | EV / Sales 2024 * | 7.65 x |
Net Debt 2024 * | 19.4B 2.79B | Net Debt 2025 * | 18.07B 2.6B | EV / Sales 2025 * | 7 x |
P/E ratio 2024 * |
35.9
x | P/E ratio 2025 * |
30.7
x | Employees | 15,930 |
Yield 2024 * |
2.41% | Yield 2025 * |
2.64% | Free-Float | 58.44% |
Latest transcript on Coloplast A/S
1 day | +1.34% | ||
1 week | +3.42% | ||
Current month | +2.59% | ||
1 month | +0.26% | ||
3 months | -12.33% | ||
6 months | +13.07% | ||
Current year | +9.61% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 07-12-31 | |
Director of Finance/CFO | 52 | 05-12-31 | |
Chairman | 65 | 87-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 68-09-30 | |
Carsten Hellmann
BRD | Director/Board Member | 60 | 17-11-30 |
Chairman | 65 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.81% | 218 M€ | +17.05% | ||
1.11% | 252 M€ | +8.06% | ||
0.96% | 51 M€ | +7.22% | ||
0.85% | 3 M€ | +9.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 844.8 | +1.34% | 279 575 |
24-06-10 | 833.6 | -0.86% | 239,590 |
24-06-07 | 840.8 | +1.35% | 280,671 |
24-06-06 | 829.6 | +1.39% | 328,513 |
24-06-04 | 818.2 | +1.39% | 179,324 |
Delayed Quote Nasdaq Copenhagen, June 11, 2024 at 10:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.61% | 26.99B | |
-41.92% | 2.63B | |
+25.56% | 2.44B | |
-23.19% | 2.31B | |
+5.99% | 2.21B | |
+21.11% | 1.87B | |
-14.16% | 1.81B | |
+30.22% | 1.37B | |
+32.97% | 1.33B | |
+0.25% | 1.3B |
- Stock Market
- Equities
- COLO B Stock